A U.S. startup is trying to put an end to all speculations on what cannabis can or can’t do. Colorado-based Sunrise Genetics will tread a new path by producing the first-ever full map of the cannabis genome.
“DNA, of course, I’m biased because it’s what I do, but it doesn’t lie. It really is a way to just sort of clear a lot of the b.s.,” CJ Schwartz, the chief executive officer of Sunrise Genetics, in Fort Collins, told Bloomberg in an interview published on Wednesday.
“The excessive claims are really doing a disservice to the plant or the potential of the plant and the science surrounding that.”
Some are probably pitching far-fetched claims, saying that marijuana can cure cancer. While others, who use some scientific data to arbitrarily give their own interpretation, say that our bodies are built with cannabinoid receptors specifically designed to tetrahydrocannabinol (THC), one of the primary active components of marijuana.
A further understanding of the marijuana DNA makeup, will not only verify all these assertions but it can further enhance and improve one’s marijuana experience.
The research can help modify recreational products by examining how it could affect the body and the mind, Schwartz said.
It has already been known that certain marijuana strains can make one sleepy and others are the opposite, make people rather active.
It is not a surprise that a Colorado company is going after marijuana’s DNA story. Colorado was one of the first U.S. states to legalize marijuana in 2014.
The company’s idea was to take well-established genetic tools used for other crops and apply them to marijuana.